Thymopoietin II: 32-34

Modify Date: 2025-08-25 15:59:46

Thymopoietin II: 32-34 Structure
Thymopoietin II: 32-34 structure
Common Name Thymopoietin II: 32-34
CAS Number 85465-82-3 Molecular Weight 417.46100
Density 1.51g/cm3 Boiling Point N/A
Molecular Formula C16H31N7O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Thymopoietin II: 32-34


Thymotrinan (RGH-0205) is a biologically active fragment of the naturally occurring thymus hormone thymopoietin and a immunomodulating peptide. Thymotrinan exerts similar immunomodulatory activities to TP5 and to affect humoral as well as cellular responses[1].

 Names

Name (2S)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]butanedioic acid
Synonym More Synonyms

 Thymopoietin II: 32-34 Biological Activity

Description Thymotrinan (RGH-0205) is a biologically active fragment of the naturally occurring thymus hormone thymopoietin and a immunomodulating peptide. Thymotrinan exerts similar immunomodulatory activities to TP5 and to affect humoral as well as cellular responses[1].
Related Catalog
References

[1]. Heizmann J, et al. Enzymatic cleavage of thymopoietin oligopeptides by pancreatic and intestinal brush-border enzymes. Peptides. 1996;17(7):1083-1089.

 Chemical & Physical Properties

Density 1.51g/cm3
Molecular Formula C16H31N7O6
Molecular Weight 417.46100
Exact Mass 417.23400
PSA 246.74000
LogP 0.60820
Index of Refraction 1.633

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CI9099033
CHEMICAL NAME :
L-Aspartic acid, N-(N(sup 2)-L-arginyl-L-lysyl)-
CAS REGISTRY NUMBER :
85465-82-3
LAST UPDATED :
199407
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C16-H31-N7-O6
MOLECULAR WEIGHT :
417.54

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986

 Synonyms

Rgh 0205
Thymotrinanum [INN-Latin]
Arg-Lys-Asp
Thymotrinanum
N-(N(sup 2)-L-Arginyl-L-lysyl)-L-aspartic acid
Timotrinan
Timotrinan [INN-Spanish]
L-Aspartic acid,N-(N(sup 2)-L-arginyl-L-lysyl)
Thymotrinan
Thymopoietin II: 32-34
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Thymopoietin II: 32-34 suppliers

Thymopoietin II: 32-34 price

Related Compounds: More...
Thymopoietin II: 32-35
85466-18-8
6,14,16,24,32,34-Hexahydroxy-4,8,12,22,26,30-nonatriacontanehexone
79065-98-8
(6R,14R,22R,30R,32S,34S)-6,14,22,30,32,34-Hexahydroxy-8,16,24-pentatriacontanetrione
87879-55-8
Cyclostelletamines B
156953-87-6
36-bromo-3,6,9,12,15,18,21,24,27,30-decaoxabicyclo[30.3.1]hexatriaconta-1(36),32,34-triene
102096-98-0
Thymopoietin II (32-36)-ethyl ester
283167-49-7
THYMOPOIETIN II (34-36)
75958-14-4
(3S)-3-[[(2S)-6-amino-2-[[(2S)-5-(diaminomethylideneamino)-2-[(3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)carbamothioylamino]pentanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-3-methyl-1-oxobutan-2
107865-24-7
thymopoietin III
79103-34-7
2-[4-(2-chlorophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-N-(1-cyanocyclohexyl)acetamide
1008446-55-6
N-(1-cyanocyclohexyl)-2-(4-cyclopropyl-4-methyl-2,5-dioxoimidazolidin-1-yl)acetamide
1172078-37-3
4-(benzylthio)-N-(4,5-dihydronaphtho[1,2-d]thiazol-2-yl)butanamide
923430-68-6
2-(2,4-dichlorophenyl)-N-(1H-pyrazol-4-yl)acetamide
1154953-36-2
4-(benzylthio)-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)butanamide
923430-96-0
3,6-dichloro-N-(3-methyl-1,1-dioxo-1lambda6-thiolan-3-yl)pyridine-2-carboxamide
1111536-72-1
3-(2,5-Dimethyl-1H-pyrrol-1-yl)butanoic acid
1099126-93-8
3-(dimethylamino)-N-(1H-pyrazol-4-yl)benzamide
1153793-49-7
Benzyl N-[1-(cyclopentylcarbamoyl)-2-phenylethyl]carbamate
1214091-36-7
1-Benzhydryl-3-((1-(2-fluorobenzoyl)piperidin-4-yl)methyl)urea
1235091-54-9